Viewing Study NCT04659733


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-01-06 @ 2:25 AM
Study NCT ID: NCT04659733
Status: UNKNOWN
Last Update Posted: 2020-12-09
First Post: 2020-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
Sponsor: Yizhuo Zhang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module